These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5309002)

  • 1. A study on the possible relationships between certain morphological and physiological properties of Aspergillus fumigatus Fres. and its presence in, or on, human and animal (pulmonary) tissue.
    De Vries GA; Cormane RH
    Mycopathol Mycol Appl; 1969 Dec; 39(3):241-53. PubMed ID: 5309002
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of antifungal compounds on aspergillosis in hatching chick embryos.
    Huhtanen CN; Pensack JM
    Appl Microbiol; 1967 Jan; 15(1):102-9. PubMed ID: 5298442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal drug resistance in Aspergillus.
    Moore CB; Sayers N; Mosquera J; Slaven J; Denning DW
    J Infect; 2000 Nov; 41(3):203-20. PubMed ID: 11120607
    [No Abstract]   [Full Text] [Related]  

  • 4. The development of resistance by candida species to polyene antibiotics in vitro.
    Athar MA; Winner HI
    J Med Microbiol; 1971 Nov; 4(4):505-17. PubMed ID: 5316339
    [No Abstract]   [Full Text] [Related]  

  • 5. Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from keratitis.
    Lalitha P; Shapiro BL; Loh AR; Fothergill AW; Prajna NV; Srinivasan M; Oldenburg CE; Quigley DA; Chidambaram JD; McLeod SD; Acharya NR; Lietman TM
    Br J Ophthalmol; 2011 May; 95(5):744-5. PubMed ID: 21030412
    [No Abstract]   [Full Text] [Related]  

  • 6. Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates.
    Reichert-Lima F; Lyra L; Pontes L; Moretti ML; Pham CD; Lockhart SR; Schreiber AZ
    Mycoses; 2018 Jun; 61(6):360-365. PubMed ID: 29468746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resistance of fungi to antifungal antibiotics].
    Drouchet E
    Pathol Biol; 1967 Dec; 15(23):1222-6. PubMed ID: 4867327
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species.
    Misra R; Malik A; Singhal S
    Indian J Pathol Microbiol; 2011; 54(1):112-6. PubMed ID: 21393890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimycotic antibiotics (author's transl)].
    van Miert AS; van Soeren JH; Hagens FM
    Tijdschr Diergeneeskd; 1976 Aug; 101(16):900-4. PubMed ID: 1085044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD; Kiraz N
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of Aspergillus strains from culture collections to amphotericin B and itraconazole.
    Rath PM
    J Antimicrob Chemother; 1998 May; 41(5):567-70. PubMed ID: 9630411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
    Warn PA; Morrissey G; Morrissey J; Denning DW
    J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B.
    Escribano P; Peláez T; Recio S; Bouza E; Guinea J
    Clin Microbiol Infect; 2012 Feb; 18(2):E24-6. PubMed ID: 22128886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole.
    Chryssanthou E
    Scand J Infect Dis; 1997; 29(5):509-12. PubMed ID: 9435042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study.
    Risslegger B; Zoran T; Lackner M; Aigner M; Sánchez-Reus F; Rezusta A; Chowdhary A; Taj-Aldeen SJ; Arendrup MC; Oliveri S; Kontoyiannis DP; Alastruey-Izquierdo A; Lagrou K; Lo Cascio G; Meis JF; Buzina W; Farina C; Drogari-Apiranthitou M; Grancini A; Tortorano AM; Willinger B; Hamprecht A; Johnson E; Klingspor L; Arsic-Arsenijevic V; Cornely OA; Meletiadis J; Prammer W; Tullio V; Vehreschild JJ; Trovato L; Lewis RE; Segal E; Rath PM; Hamal P; Rodriguez-Iglesias M; Roilides E; Arikan-Akdagli S; Chakrabarti A; Colombo AL; Fernández MS; Martin-Gomez MT; Badali H; Petrikkos G; Klimko N; Heimann SM; Houbraken J; Uzun O; Edlinger M; Fuente S; Lass-Flörl C
    Clin Microbiol Infect; 2017 Oct; 23(10):776.e1-776.e5. PubMed ID: 28412383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of combination of polyenes with EDTA against Aspergillus spp. by different methods (FICI and CI Model).
    Ruhil S; Kumar V; Balhara M; Malik M; Dhankhar S; Kumar M; Kumar Chhillar A
    J Appl Microbiol; 2014 Sep; 117(3):643-53. PubMed ID: 24931000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.
    Lass-Flörl C; Kofler G; Kropshofer G; Hermans J; Kreczy A; Dierich MP; Niederwieser D
    J Antimicrob Chemother; 1998 Oct; 42(4):497-502. PubMed ID: 9818749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies.
    Colozza C; Posteraro B; Santilli S; De Carolis E; Sanguinetti M; Girmenia C
    Int J Antimicrob Agents; 2012 May; 39(5):440-3. PubMed ID: 22429723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
    Manavathu EK; Cutright JL; Loebenberg D; Chandrasekar PH
    J Antimicrob Chemother; 2000 Aug; 46(2):229-34. PubMed ID: 10933645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
    Öz Y; Özdemir HG; Gökbolat E; Kiraz N; Ilkit M; Seyedmousavi S
    Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.